Visceral Pain Market Report 2024 - Future Challenges, Growth Opportunities, Upcoming Trends, Industry Demand And Forecast To 2033

 

Overview and Scope

Visceral pain refers to the pain that originates from the internal organs, such as the stomach, bladder, uterus, or rectum. Visceral pain can be caused by various factors, including inflammation, menstrual cramps, swelling and stretching of the organs, blockage, decreased blood flow, and tumors, especially when concentrated in the pelvis or abdomen. It is commonly associated with additional symptoms such as nausea, perspiration, or an accelerated heartbeat.

 

Sizing and Forecast

The visceral pain treatment market size has grown strongly in recent years. It will grow from $12.87 billion in 2023 to $13.84 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%.  The growth in the historic period can be attributed to aging population, increased incidence of chronic diseases, advances in medical research, expansion of healthcare infrastructure, rising awareness and diagnosis rates.

 

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

 

Segmentation & Regional Insights

The visceral pain market covered in this report is segmented –

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

 

North America was the largest region in the visceral pain market in 2023. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

 

Major Driver Impacting Market Growth

The rising demand for analgesics is expected to fuel the growth of the visceral pain market going forward. Analgesics refer to medications that alleviate pain by diminishing or blocking the perception of pain signals in the brain. Analgesics help manage visceral pain by targeting the nervous system and modulating pain signals originating from internal organs. For instance, in December 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based, science-based, data-driven organization that protects public health in the United States, meticulously documented, a total number of dispensed Buprenorphine (an opioid analgesic) prescriptions saw a notable increase from 16,011,239 in 2020 to 16,105,318 in 2021, which represents a notable 0.59% increase when contrasted with the corresponding period in 2020. Therefore, the rising demand for analgesics is driving the growth of the visceral pain market.

 

Key Industry Players

Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd., , , , , ,

 

The visceral pain market report table of contents includes:

1. Executive Summary

2. Visceral Pain Market Characteristics

3. Visceral Pain Market Trends And Strategies

4. Visceral Pain Market - Macro Economic Scenario

5. Global Visceral Pain Market Size and Growth

................................

32. Global Visceral Pain Market Competitive Benchmarking

33. Global Visceral Pain Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Visceral Pain Market

35. Visceral Pain Market Future Outlook and Potential Analysis

36. Appendix

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info 

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model